Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes Angelo, I planned to stay here for 2 to 5yrs...or LESS ! LoL
the are buying and selling to each other account, and trying to cover in the process without getting too burned.
I truly hope we get a partner for Glugophage announced by monday, with indication the will start to produce and deliver asap.
I got a question for you and Others who can help me with this:
IPCI is indicating 2.7Bln market on all its communication, but this was on Bloomberg, from Newswire "According to Symphony Health Solutions, sales in the United States for the 12 months ended January 2017 of the 500 mg and 750 mg strengths of Glucophage® XR and all generic equivalents, were approximately $591 million (TRx MBS Dollars, which represents projected new and refilled prescriptions representing a standardized dollar metric based on manufacturer's published catalog or list prices to wholesalers, and does not represent actual transaction prices and does not include prompt pay or other discounts, rebates or reductions in price)."
Now they have to partner it and hopefully they were prepared and we will be having an announcement soon.
Will be nice if some of recent days' shorts were made "naked" (without having borrowed the stock first); in that case they will run to cover.
What is important here is that pipeline is progressing, and FDA is validating ANDAs technology.
GLTA
Agreed. strongly agreed. Shorting and accumulating, plus a little ATM.
I think that around 5/6 accounts with 500k USD each are playing the game.
I would also point to everyone that Cysonic has been the only one in commenting Odidi interview linked on this board a couple of hours ago.
It seems clear Odidi is keeping more than something under the radar. Why?
declaes I agree, they can raise without dilution.
I was just point out to something that could have triggered the heavy sell orders. so just trying to give na explanation to the big down day when result were released.
Now let's hope something exciting gets out from the meeting.
We will have a special section for Xcede there...should be very interesting
from my understanding it is not for Xcede, but it is another potential acquisition: see below
from the last CC
"The other thing I mentioned in my prepared remarks is that we are looking at a potential acquisition that could assist with Xcede. It had -- they have a number of employees already, it's an operating company as oppose to a development stage company, and so it's significantly different than Xcede is at the moment.
But it could really jump-start that business, if we can pull it off. We don't have the money to do it, we would have to raise the money. We're not real clear on what that structure would look like yet, there's a lot of imponderables about this thing at the moment. But the first step is, if we have done some due diligence we visited the company a few times, we believe that it's an acquisition that is worth doing, if we -- if it's accepted. And -- but there's a lot of time, distance and work that has to be done before we get to that plan. And even if we are now -- if our LOI is accepted it's not likely that we would close this transaction for about six months, would be our guess. But it does give us yet another option in the value proposition of Xcede so."
I think u could be right. Below 2 if we see a market correction. Sad but it seems inevitable
Agreed on everything,
IPCI is really bad in investor relations, and I mean REALLY.
They don't care about share price, which is nonsense for a listed company (but I see many examples every day).
Amigo,
I am adding one point to your considerations: ATM is affecting the share price (I had the impression that many of trades happened last week @ 2.50 were new shares)
but
as of 31 of Jan the Short Interest reached new historical highs, with 1.83Ml shares short (up more than 200K compared to 15 of jan).
This is a remarkable point to me: as the company slowly progresses through its development the shorts are mounting. So while logic would suggest a sidelines share price if not slightly upward, we see bearish bets increasing.
This reaffirms my feeling (just that) that we will have all at once; I can even see partnership announced and a down day. Then we have to pray for the labeling.
This company, with all its issues in communication and management, not so uncommon for tiny caps, it is just being played (like many Others in the market). DD is Paramount, but I think right now we have the concentrate our attention on shares dyanmics as well if not mostly)
JMHO
wmike, I agree.
the only valid reason for considering a possible lawsuit from Purdue a non event is if you are in talk with Purdue for partnering.
Otherwise if the company is proven wrong or overly optimistic then it will get hammered by the market.
JMHO
I agree, but we are talking about speculators and not investors.
Don't know why I started with "pink"...
..oh yes, now I remember..Elite, WZ, pink-OTC...that kind of association
LOL
Oh no, Amigo,
now WZ will start over with pink dye, red dye, Yellow dye... LOL
They push the price down, waiting for possible dilution; then, when the price looks particularly cheap (new shares issue or not) then they jump in.
tiny caps are played until the company is able to dissolve uncertainty (whatever it is)
Fingers crossed for the weeks to come
Odidi is working hard to make his dream (and ours) come true
Samsa, you are wasting your time. He just want the share price to go down and he is going crazy because is loosing big time on ELTP.
You and others are too kind persons and these little ...... Don't deserve your efforts and willingness. Forget them
they want to trigger the max possible stops; expect a flash crash anytime.
we have no more floating and a bounch of speculators playing their toy.
Disgusting, but we know it's disconnected with fundamentals.
And it's not the only disconnected phenomenon around here as of lately. LOL
PS
as I was writing it started to happen
I believe the statement I outlined about the CC, where they say they have no money for the potential M&A is the reason we may have even lower prices.
I do agree there is some huge potential development, but as far as the masrket sees the potential for dilution...
Anyway if it goes down I am ready to buy more.
GLTY
Angelo, Amigo, what's the implications of the expression used by Della "plug and play" referred to Rexista with a big pharma?
TIA
Pag 29 of presentation shows convertible debt @ 0.5. so they reduced it or am I wrong somewhere?
Cysonic, @ pag 29, convertible debt is indicated as 0.5Mln. I thought that after the financial results we were talking about more than 1mln still to be reimbursed. Is it the 12% Odidi's ?
or am i wrong in something ?
TIA
unbelievable as each of institutions showed there has less shares than many of us here on this board have.
They just have to stick with their own advertised strategy
http://www.intellipharmaceutics.com/new_chemical_entities.cfm
I have the impression that there are too few key persons for too many strategic potentials. That's why they don't even PR a new Andas filing
Hei Doog, I remember that a while back IPCI or Odidi toold that they planned to put 2 new ANDAs per year, is my memory serving well ?
I thought they completely suspended the ANDAs strategy, but this recent Ranexa filing seems to confirm otherwise.
even if this confirms how bad the company is in investor relations, on the other side is telling that R&D is alive and kicking.
from company CC
"The other thing I mentioned in my prepared remarks, we are looking at a potential acquisition that could assist with Xcede it had -- they have a number of employees already it's an operating company as supposed to a development stage company and so it's significantly different than Xcede is at the moment.
But it could really jump-start that business, if we can pull it off. We don't have the money to do it, we would have to raise the money[/b] we're not real clear on what that structure would look like yet, there's a lot of imponderables about this thing at the moment. But the first step is if we have done some due diligence we visited the company a few times, we believe that it's an acquisition that is worth doing."
peak in volume with a very negative day; what is your idea? it does seem pretty negative to me.
I'm disappointed
Agreed on Pharmer. Sometimes he used the same identical expressions.
You are always right, of my Wizard. That's why you are reach beyond any imagination. You discovered that Fibonacci tells you all.
Sorry if I doubted you, my master
You are right Wimus, just pointing out how unprofessional the guy is.
Either you do the analysis, modelling uncertainty using scenarios and probabilities or you just honestly say it's to tough and suspend your calculation.
Who, but we have our guru here and the wizard of chart, which by way is always very precise in writing something only when another poster writes. LoL
Honestly Mackie analyst is in the classic case where you have a "coverage suspended".
From a professional point of view I would say he is throwing there some numbers and I would recommend him to withdraw any projection if you are the first to say I don't know exactly how to do it.
And I'm not saying he hasn't good reasons... Just you cannot say what he is writing. He has no more credibility to me.
OK Sprot,
fingers crossed for your buy to happen sooooon and at the bottom...and I mean the bottom for years to come !
GLTY
Is Rexista-Mallinckrodt out ?
was thinking if the recent subpoena could eventually push MNK to make a step down for possible Rexista partnership ?
Still vote for Purdue as the best partner. Also the idea of potentially becoming delisted could really look sexy to a man like Odidi.
"Mallinckrodt received an SEC subpoena for documents related to statements, filings and other disclosures on Acthar sales, profits, revenue, promotion and pricing.
Filing also mentions subpoena received in Dec. from U.S. Attorney’s Office in Mass. for documents related to patient support, including through charitable foundations"
keppra bonus to me looks like an insult to shareholders, not being cash it just make it a mild insult . LOL
Good points Samsa.
On the Odidi's Convertible: I would have preferred to see it 3x on july rather than the new shares issue + warrants; I consider difficult for a company like IPCI to get bank loan (I would say impossible; no assets as collateral). So that 12% looks bad and would like to have it reimbursed...Yesterday. LOL
...but, I'm expecting a double digit interest on any loan given by those specialty players in the biotech space.
On communication: seeing a new ANDA without a PR it's very disappointing. But I have to be honest here: it fits with my gut feeling that we will have all at once.
Odidi doesn't remotely care about shareholders and market forces; he is going to build his creature with share price likely to remain well undervalued as the progress in the pipeline goes.
Then, a big palyer will just model an Excel and will get same numbers Angelo or you (or me, with my conservative 20per share based on all ANDAs) and say:
Ok, I'll take over the company considering Prordas and Regabatin almost for free.
So still a long frustration for us, then in one year we'll wake up..and that's a done deal.
This is what I see based on the Odidi attitude.
that's music to my ears
"All the discussions here about Odidis loan, bonuses etc will disappear within the months to come. I'm VERY confident we'll more discuss how long it will be until one of the big pharmas buys up IPCI, especially when IPCI starts to speed up the development of Regabatin and PODRAS."
Samsa,
all deserved.
It's a real pleasure to come here on board everyday and reading your messages and the others' as well, and confronting different thesis and aspects.
This morning I woke up with this idea (I just incidentally bumped in for my job reasons):
the team I mentioned could seriously form a "friendly activist Group" approaching the company; asking a contact with Della Penna and presenting him the concept of "friendly activism", a true win-win.
I strongly believe that a short presentation, focusing on some points, giving possibly new perspectives, could be rewarded in the future.
I can assure you it is something that is done with much bigger companies than IPCI.
The main issue I see with this approach is to be considered acting as one, being in reality and formally a Group of retailers. So to get the ok for a meeting it is all but easy.
But here the key word would be "friendly" - we are shareholder, we just wanna help build more value, for free (which is much less than paid consultants LoL). You win, I win.
Why should they pay attention to you ? Interest alignement.
Guys, just an idea, but sometimes...too bad I'm in swizerland, I would try to convince each one of you in person.
I would also have Cysonic into the Dream AdvisoryTeam
IPCI AdCom : I would strongly vote for being on a permanent advisory committee for IPCI board:
Angelo
Amigo Mike
Numbers
Samsa
No offense to all the others, but I think that they can give much better advise to the company, if not the best possible on:
Strategy
Legal
Investor Relations
Fincial Markets dynamics
I would also hire Doog as a permanent motivator in reaching the max shareholder value.
Seriously guys, let's set up a meeting with Odidi and then show him the win-win path to prosperity.
IPCI really needs you so badly.
Thank you for all you are sharing
My hope is that Odidi is not going to delay any further the partnership. I can consider as the max acceptable to wait until the window Purdue has for potential legal action is expired. The longer it goes the weaker he becomes as negotiator.
By the way this would mean Purdue is not the partner, too bad.
Today's fin report is a non event, except for those expecting an announcement of a partner.
Another point: what about possible expansion if funding is available mentioned in the PR ? A facility in the US?
My compliments as well Cysonic,
I think that whoever understands about reading a financial reports can make a clear assessment of what's the meaning of 1.17Mln usd of non financial expenses recorded into the Income Statement.
Thanks !!